![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CNRIP1 |
Gene summary for CNRIP1 |
![]() |
Gene information | Species | Human | Gene symbol | CNRIP1 | Gene ID | 25927 |
Gene name | cannabinoid receptor interacting protein 1 | |
Gene Alias | C2orf32 | |
Cytomap | 2p14 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | Q96F85 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
25927 | CNRIP1 | ATC11 | Human | Thyroid | ATC | 5.35e-04 | 2.81e-01 | 0.3386 |
25927 | CNRIP1 | ATC12 | Human | Thyroid | ATC | 4.05e-02 | 4.87e-02 | 0.34 |
25927 | CNRIP1 | ATC13 | Human | Thyroid | ATC | 1.04e-27 | 4.13e-01 | 0.34 |
25927 | CNRIP1 | ATC2 | Human | Thyroid | ATC | 9.94e-09 | 5.87e-01 | 0.34 |
25927 | CNRIP1 | ATC3 | Human | Thyroid | ATC | 6.30e-07 | 3.35e-01 | 0.338 |
25927 | CNRIP1 | ATC5 | Human | Thyroid | ATC | 6.67e-24 | 4.60e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CNRIP1 | SNV | Missense_Mutation | c.382N>C | p.Glu128Gln | p.E128Q | Q96F85 | protein_coding | deleterious_low_confidence(0) | benign(0.031) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
CNRIP1 | SNV | Missense_Mutation | c.145G>C | p.Glu49Gln | p.E49Q | Q96F85 | protein_coding | tolerated(0.14) | possibly_damaging(0.583) | TCGA-GM-A2D9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
CNRIP1 | SNV | Missense_Mutation | novel | c.433T>C | p.Tyr145His | p.Y145H | Q96F85 | protein_coding | deleterious(0) | probably_damaging(0.918) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CNRIP1 | SNV | Missense_Mutation | rs373164214 | c.290N>T | p.Thr97Met | p.T97M | Q96F85 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3488-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | PD |
CNRIP1 | SNV | Missense_Mutation | rs139324099 | c.304C>T | p.Arg102Trp | p.R102W | Q96F85 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CNRIP1 | SNV | Missense_Mutation | novel | c.269N>G | p.Asp90Gly | p.D90G | Q96F85 | protein_coding | deleterious(0.03) | possibly_damaging(0.495) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CNRIP1 | SNV | Missense_Mutation | rs748240304 | c.91N>T | p.Arg31Cys | p.R31C | Q96F85 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CNRIP1 | SNV | Missense_Mutation | novel | c.245N>T | p.Arg82Ile | p.R82I | Q96F85 | protein_coding | tolerated(0.18) | benign(0.022) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CNRIP1 | SNV | Missense_Mutation | rs377749015 | c.257N>T | p.Thr86Met | p.T86M | Q96F85 | protein_coding | deleterious(0.01) | possibly_damaging(0.71) | TCGA-A5-A0VP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CNRIP1 | SNV | Missense_Mutation | novel | c.25N>T | p.Arg9Cys | p.R9C | Q96F85 | protein_coding | deleterious(0) | possibly_damaging(0.649) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |